Affectation of the quality of life generated by vitíligo with genital compromise in adult women residing in the Colombian Caribbean

Article Sidebar

PDF (Español (España)) HTML (Español (España))
Published: May 14, 2024
DOI: https://doi.org/10.21676/2389783X.5770
Keywords:
Vitiligo, Quality of Life, Genitalia female, Psychosocial impact, Mental Health, Skin Diseases

Main Article Content

Alvaro Monterrosa-Castro
Universidad de Cartagena
Isabel Torres-Castilla
Ana Castro-Caro

Abstract

Introduction: Female genital vitíligo affects the skin of the vulva and can be isolated or generalized. Objective: To identify the magnitude of the impact on quality of life (QoL), its consequences, the psychosocial burden, and the impact generated by vitíligo with genital involvement. Method: A descriptive study was designed with adult women with genital vitíligo and residents of the Colombian Caribbean. QoL, its consequences, psychosocial burden, and the impact of vitíligo were evaluated with the Dermatology Life Quality Index and Vitíligo Impact Scale. Results: 78 women participated. The mean of age was 46.8 (±12.5), 69.2% were "great" or "extremely great" in terms of QoL impairment in 79% because of the limitation in interpersonal relationships or sexuality, and in 97.4%, the psychosocial impact was high. The affectation of QoL. Conclusions: Vitíligo generates a high impact and great magnitude in affecting QoL in women.

Downloads

Download data is not yet available.

Article Details

How to Cite
Monterrosa-Castro, A., Torres-Castilla, I., & Castro-Caro, A. (2024). Affectation of the quality of life generated by vitíligo with genital compromise in adult women residing in the Colombian Caribbean. Duazary, 21(1), 19–32. https://doi.org/10.21676/2389783X.5770
Issue
Vol. 21 No. 1 (2024): (enero-marzo)
Section
Articles of scientific and technological research
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Commercial use of the original work or of possible derivative works is not allowed, the distribution of which must be done with a license equal to that which regulates the original work.
 
 
 
 

References

Walker M. Human skin through the ages. Int J Pharm. 2022;622:121850. https://doi.org/10.1016/j.ijpharm.2022.121850

Salama AH, Alnemr L, Khan AR, Alfakeer H, Aleem Z, Ali-Alkhateeb M. Unveiling the Unseen Struggles: A Comprehensive review of vitíligo's psychological, social, and quality of life impacts. Cureus. 2023;15:e45030. https://doi.org/10.7759/cureus.45030

Bergqvist C, Ezzedine K. Vitíligo: A review. Dermatology. 2020;236:571-592. https://doi.org/10.1159/000506103

Sarhan D, Mohammed GF, Gomaa AH, Eyada MM. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitíligo with and without genital affection. J Sex Marital Ther. 2016;42:267-276 https://doi.org/10.1080/0092623X.2015.1010678

Picardo M, Huggins RH, Jones H, Marino R, Ogunsola M, Seneschal J. The humanistic burden of vitíligo: A systematic literature review of quality-of-life outcomes. J Eur Acad Dermatol Venereol. 2022;36:1507-1523. https://doi.org/10.1111/jdv.18129

Liang X, Guo F, Cai X, Wang J, Chen J, Liu L, et al. Association between vitíligo and sexual dysfunction: current evidence. Ann Med. 2023;55:946-953. https://doi.org/10.1080/07853890.2023.2182906

Wu JH, Cohen BA. The stigma of skin disease. Curr Opin Pediatr. 2019;31:509-514. https://doi.org/10.1097/MOP.0000000000000792

Roman J. Beauty That Is more than skin deep. JAMA Dermatol. 2016;152:562-563. https://doi.org/10.1001/jamadermatol.2015.4762

Amer AA, Gao XH. Quality of life in patients with vitíligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55:608-614. https://doi.org/10.1111/ijd.13198

Maamri A, Badri T. Sexual disorders in patients with vitíligo. Tunis Med. 2021;99(5):504-505.

Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Vitíligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitíligo and related issues: the Vitíligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25:E1-13. https://doi.org/10.1111/j.1755-148X.2012.00997

Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the Vitíligo Impact Scale-22 (VIS-22), a vitíligo-specific quality-of-life instrument. Br J Dermatol. 2014;171:1084-1090. https://doi.org/10.1111/bjd.13093

Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-577.

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol. 2005;125:659-664. https://doi.org/10.1111/j.0022-202X.2005.23621.x

Krüger C, Schallreuter KU. Cumulative life course impairment in vitíligo. Curr Probl Dermatol. 2013;44:102-117. https://doi.org/10.1159/000350010

Rencz F, Gergely LH, Wikonkál N, Gáspár K, Péntek M, Gulácsi L, et al. Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI-Relevant (DLQI-R) scoring. J Eur Acad Dermatol Venereol. 2020;34:e484-486. https://doi.org/10.1111/jdv.16398

De Tiedra A, Mercadal J, Badia X, Mascaro JM, Herdman M, Lozano R. Transcultural adaptation of the questionnaire Dermatology Life Quality Index (DLQI): El Índice de Calidad de Vida en Dermatología. Actas Dermosifiliogr. 1998;89:692-700.

Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitíligo impact scale: an instrument to assess the psychosocial burden of vitíligo. Indian J Dermatol Venereol Leprol. 2013;79:205-210. https://doi.org/10.4103/0378-6323.107637

Gupta V, Sreenivas V, Mehta M, Ramam M. What do vitíligo impact scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2019;180:580-585. https://doi.org/10.1111/bjd.17040

Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Ballanger F, et al. Living with vitíligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173:607-609. https://doi.org/10.1111/bjd.13839

Elbuluk N, Ezzedine K. Quality of Life, burden of disease, co-morbidities, and systemic effects in vitíligo patients. Dermatol Clin. 2017;35:117-128. https://doi.org/10.1016/j.det.2016.11.002

Silverberg JI, Silverberg NB. Association between vitíligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149:159-164. https://doi.org/10.1001/jamadermatol.2013.927

Peralta-Pedrero ML, Guerrero-Oliva G, Morales-Sánchez MA, Chirino-Castillo GQ, Marín-Rivera D, et al. What is the quality of life of adults with vitíligo in Mexico? Gac Med Mex. 2022;158:393-400 https://doi.org/10.24875/GMM.M22000718

Ongenae K, Beelaert L, van Geel N, Naeyaert JM. Psychosocial effects of vitíligo. J Eur Acad Dermatol Venereol. 2006;20:1-8. https://doi.org/10.1111/j.1468-3083.2005.01369.x

Bhandarkar SS, Kundu RV. Quality-of-life issues in vitíligo. Dermatol Clin. 2012;30:255-268. https://doi.org/10.1016/j.det.2011.11.013

Morrison B, Burden-Teh E, Batchelor JM, Mead E, Grindlay D, Ratib S. Quality of life in people with vitíligo: a systematic review and meta-analysis. Br J Dermatol. 2017;177:e338-339. https://doi.org/10.1111/bjd.15933

Sukan M, Maner F. The problems in sexual functions of vitíligo and chronic urticaria patients. J Sex Marital Ther. 2007;33:55-64. https://doi.org/10.1080/00926230600998482

Fatani MI, Aldhahri RM, Al Otaibi HO, Kalo BB, Khalifa MA. Acknowledging popular misconceptions about vitíligo in western Saudi Arabia. J Dermatol Dermatologic Surg. 2016;20:27-31. https://doi.org/10.1016/j.jdds.2015.09.001

Osinubi O, Grainge MJ, Hong L, Ahmed A, Batchelor JM, Grindlay D, et al. The prevalence of psychological comorbidity in people with vitíligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178:863-878. https://doi.org/10.1111/bjd.16049

Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitíligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177:708-718. https://doi.org/10.1111/bjd.15199

Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitíligo: a meta-analysis. J Eur Acad Dermatol Venereol. 2018;32:1343-1351. https://doi.org/10.1111/jdv.14739

Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitíligo. Lancet. 2015;386:74-84. https://doi.org/10.1016/S0140-6736(14)60763-7

Krüger C, Schallreuter KU. Cumulative life course impairment in vitíligo. Curr Probl Dermatol. 2013;44:102-117. https://doi.org/10.1159/000350010

Morales-Sánchez MA, Vargas-Salinas M, Peralta-Pedrero ML, Olguín-García MG, Jurado-Santa Cruz F. Impacto del vitíligo en la calidad de vida. Actas Dermo-Sifiliográficas 2017;108:637-642. https://doi.org/10.1016/j.ad.2017.03.007

Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, et al. The Vitíligo Impact Patient Scale (VIPs): Development and validation of a Vitíligo Burden Assessment Tool. J Invest Dermatol. 2016;136:52-58. https://doi.org/10.1038/JID.2015.398

Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. https://doi.org/10.1097/00005650-199603000-00003

Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitíligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69:e11-18. https://doi.org/10.1016/j.jaad.2012.01.038

Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in vitíligo. J Drugs Dermatol. 2018;17:688-691

Most read articles by the same author(s)